RiboMed Biotechnologies, Inc.
BiotechnologyArizona, United States0-1 Employees
RiboMed Biotechnologies, Inc. is a molecular diagnostic company based in Phoenix, Arizona, focused on identifying epigenetic and genetic biomarkers linked to disease initiation, progression, and treatment response. Its work centers on detecting DNA methylation and DNA variants such as mutations or SNPs to support personalized medicine, including applications in disease management and drug development. The company offers products and services for epigenetic research and assay development, leveraging its proprietary detection and methylation isolation technologies. While the organization operates in the biotechnology research sector with a lean team, its market likely includes researchers and developers seeking biomarker-based tools for biomarker discovery and clinical interpretation. The description notes a current emphasis on epigenetic biomarker (DNA methylation) and genetic biomarker (DNA mutations/SNPs) detection as central to its offerings, and positions its location in the Phoenix area as part of its operational base.